Drawing for INSTILBIO

USPTO serial 90461121

INSTILBIO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CAYSIDO, REBECCA TOLENTINO
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INSTILBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.One East Washington Street, Suite 2700Phoenix, AZ 85004-2556United States

Goods and services

ClassDescriptionStatusFirst use
001Cells for scientific and research use; cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulationACTIVE—
005Cells for medical and clinical use; cell growth media for growing cells for medical and clinical use and cell growth stimulatory factors being synthetic cholesterol mainly for use in growing cell cultures; white blood cell and lymphocyte growth media for growing cells for medical and clinical use and stimulatory factors in the nature of culture media for cultivating human cells; white blood cells and lymphocytes for medical and clinical use; medicaments to help assist with the regeneration of ligament and tendon fibers and cell therapies and treatments containing cells, white blood cells and lymphocytes for medical and clinical use; medical reagents for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; medical reagents for solid tumor tissue digestion, white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulationACTIVE—
010Medical specimen apparatus in the nature of needles, tubing, glass slides, cups, and bags for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefromACTIVE—
039Providing transportation services of patient tumor samples and biomedical services and methods, namely, the storage of the patient tumor samples for medical use of the patient tumor samples for tissue digestion and cell isolation and expansion, amplification, stimulation and cell growth, and human cells for medical use and storage, and cell population expansion and stimulation, and solid tumor tissue digestion and white blood cell and lymphocyte isolation and white blood cell and lymphocyte storage and white blood cell and lymphocyte expansion and amplification and white blood cell and lymphocyte growth and stimulation; providing medical transport services and biomedical services and methods, namely, the storage of human cells for medical use for treating patients having a tumor and solid tumorACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 8, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 8, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 22, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2025EX5GSOU EXTENSION 5 GRANTED—
Apr 21, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2025EXT5SOU EXTENSION 5 FILED—
Jan 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2024EX4GSOU EXTENSION 4 GRANTED—
Jul 29, 2024EXT4SOU EXTENSION 4 FILED—
Jul 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2024EX3GSOU EXTENSION 3 GRANTED—
Jan 18, 2024EXT3SOU EXTENSION 3 FILED—
Jan 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2023EX2GSOU EXTENSION 2 GRANTED—
Jul 27, 2023EXT2SOU EXTENSION 2 FILED—
Jul 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2023EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2023EXT1SOU EXTENSION 1 FILED—
Jan 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 2, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 7, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 3, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 3, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
May 3, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 6, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 6, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 6, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2021DOCKASSIGNED TO EXAMINER—
Apr 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance